ArticleHereditary cancer in clinical practice2022

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor.

Alicja Ogrodniczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.